FRANCE

Iris Pharma has fourteen years of experience in performing clinical trials in France. There are many advantages to conducting clinical trials in France:

• one of the most important markets in ophthalmology in the world
• French ophthalmologists are known to be highly competent
• high quality investigator centers
• French legislation: Huriet-Sérusclat law (20th December 1988) and Loi d´Orientation de Santé Publique (LOSP) number 2004-806 (9th August 2004)
• cost competitiveness compared with other European countries and the USA

Iris Pharma is located near the international airport of Nice in south-eastern France wich makes visits to investigator sites easy.

EUROPE

Over the last seven years, Iris Pharma has increased its European capabilities.

The European Vision Institute. Clinical Trials. Sites of Excellence (EVI.CT.SE), a network of European Ophthalmological Clinical Research Sites with the highest standards of quality, has chosen Iris Pharma to be an independant expert for optimising their network consolidation through consulting, site audits and certification.

INTERNATIONAL CAPABILITIES

To improve eye health care around the world, Iris Pharma expanded its activity in 2002 to become international. We can offer clinical studies in France, Austria,Belgium, Denmark, Eastern Europe (Bulgaria, Czech Republic, Poland, Romania), Germany, India, Israel, Italy, Morocco, North America (USA and Canada), Portugal, Saudi Arabia, Spain, Switzerland, Tunisia, Turkey, The Netherlands and the United Kingdom.